1. PROTAC Immunology/Inflammation Apoptosis
  2. PROTACs IRAK Interleukin Related TNF Receptor
  3. LZ-07

LZ-07 是一种 IRAK4 PROTAC 降解剂 (DC50 = 1.14 nM)。降解 IRAK4 后,LZ-07 可显著抑制 IL-6、IL-1β、TNF-α 和 IL-10 等细胞因子的表达。LZ-07 可用于自身免疫性疾病的研究 (粉色:IRAK4 配体 (HY-172591);蓝色:CRBN 配体 (HY-W883357);黑色:连接子 (HY-B0149);CRBN 配体 + 连接子:HY-172593)。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

LZ-07 Chemical Structure

LZ-07 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

LZ-07 is a IRAK4 PROTAC degrader (DC50 = 1.14 nM). LZ-07 leads to marked suppression of cytokines including IL-6, IL-1β, TNF-α, and IL-10 upon degradation of IRAK4. LZ-07 can be studied in research for autoimmune diseases (Pink: IRAK4 ligand (HY-172591); Blue: CRBN ligand (HY-34590); Black: linker (HY-B0149); CRBN ligand + linker: HY-172593)[1].

体外研究
(In Vitro)

LZ-07 (10-100 nM,16 小时) 在 THP-1 细胞系中表现出最强的降解活性,在 10 nM 时降解水平超过 65%,在 100 nM 时降解水平超过 75%[1]
LZ-07 (0.3-300 nM,16 小时) 在 DOHH2 和 TMD8 细胞中表现出剂量依赖性的 IRAK4 降解(DC50 分别为 1.14 nM 和 2.70 nM)[1]
LZ-07 (0.3-300 nM,0-24 小时) 在 50 nM 浓度下 4 小时内诱导快速显著的降解,在 TMD8 细胞中 16 小时时达到最大降解 (Dmax = 91%),并在 DOHH2 细胞中降解 IRAK4迅速[1]
LZ-07 (30 nM,8小时) 通过泛素-蛋白酶体系统介导 IRAK4 降解,其活性依赖于与 IRAK 和CRBN 的结合[1]
LZ-07 (3.9-7.6 nM,2小时) 在 LPS (100 ng/mL) 刺激的 PBMC 中表现出对四种关键炎症细胞因子 (IL-6、IL-10、IL-1β和TNF-α) 的优异抑制作用[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: Pretreated DOHH2 and TMD8 cells with DMSO, MG132 (HY-13259) (0.5 μM), MLN4924 (HY-70062) (0.5 μM), Pomalidomide (HY-10984) (1 μM) and Compound E (1 μM)
Concentration: 30 nM
Incubation Time: 8 h
Result: Inhibited IRAK4 degradation and the degradation was blocked by pretreatment of proteasome inhibitor MG132, the ubiquitination inhibitor MLN4924, compound E and pomalidomide.

ELISA Assay[1]

Cell Line: LZ-07 pretreated PBMCs with LPS stimulation (100 ng/mL)
Concentration: 3.9-7.6 nM
Incubation Time: 2 h pretreatment, followed by stimulation with LPS for 24 h
Result: Exhibited 131-fold greater inhibition of IL-6 compared to KT-474 (HY-145483) in PBMCs from one healthy donor.
Inhibited IL-6 with an IC50 of 4.8 nM in PBMC from another donor.
Inhibited key inflammatory cytokines including IL-6, IL-10, IL-1β and TNF-α.
分子量

812.92

Formula

C42H48N14O4

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
LZ-07
目录号:
HY-172590
需求量: